Related Experiment Video
Updated: Sep 22, 2025
08:05
Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
14.3K
[Systemic and extrapulmonary manifestations of COVID-19]
J Balsa Vázquez1, D Alonso Menchén1, M M Martín Lloréns1
1Servicio de Medicina Interna. Hospital Universitario Príncipe de Asturias. Universidad de Alcalá. Alcalá de Henares. Madrid. España.
Medicine
|May 18, 2022
Summary
COVID-19 can cause serious extrapulmonary complications affecting multiple organs, not just the lungs. Early diagnosis and individualized treatment are crucial for managing these systemic effects and ensuring patient recovery.
Area of Science:
- * Explores the diverse extrapulmonary manifestations of COVID-19.
- * Highlights the role of Angiotensin-Converting Enzyme 2 (ACE2) receptors in viral entry and multisystemic involvement.
Context:
- * While fever and respiratory symptoms are primary, COVID-19 frequently leads to significant complications in other organ systems.
- * Systemic effects can precede, accompany, or follow typical respiratory symptoms, impacting various bodily functions.
Purpose:
- * To detail the range of systemic complications associated with COVID-19.
- * To discuss diagnostic approaches and therapeutic considerations for extrapulmonary manifestations.
- * To address specific concerns regarding pregnant women and children.
Summary:
- * COVID-19 causes multisystemic involvement due to widespread ACE2 receptor distribution.
- * Thromboembolic events are a significant concern, stemming from a hypercoagulable state.
- * Cardiac, neurological, gastrointestinal, renal, endocrine-metabolic, skin, and ocular systems can be affected.
Impact:
- * Emphasizes the need for comprehensive diagnostic testing based on clinical suspicion.
- * Stresses individualized treatment strategies, often similar to those for the general population.
- * Provides insights into managing COVID-19 complications in specific populations like pregnant women and children.
Related Concept Videos
01:31Pulmonary Tuberculosis III
466
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
466
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.9K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.9K
01:29Pneumonia II: Pathophysiology
672
The pathophysiology of pneumonia involves the following steps:
672
01:28Pulmonary Tuberculosis II
407
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
407
01:20COPD: Pathogenesis and Clinical Features
582
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
582
01:17Other Pulmonary Disorders
917
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
917